Completed NA INTERVENTIONAL 1-arm NCT00733200

Surgical Treatment of Hilar Cholangiocarcinoma: Minor or Major Liver Resection?

Sponsor: Hepatic Surgery Clinical Research Centre of Hubei, China

Conditions Cholangiocarcinoma Hepatectomy Surgical Treatment

Interventions Minor or Major Liver Resection

Updated 5 times since 2017 Last updated: Dec 10, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Cholangiocarcinoma and Hepatectomy and is currently completed. Hepatic Surgery Clinical Research Centre of Hubei, China leads this study, which shows 5 recorded versions since 2026 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hepatic Surgery Clinical Research Centre of Hubei, China
Huazhong University of Science and Technology
Ministry of Health, China

Data source: Huazhong University of Science and Technology

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.